Dongwha Pharm.Co.,Ltd (KRX:000020)

Dongwha Pharm.Co.,Ltd Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	181,552	174,623	284,265	256,309	404,115	542,492
Market Cap Growth	-36.28%	-38.57%	10.91%	-36.58%	-25.51%	136.46%
Enterprise Value	273,816	241,058	195,948	161,993	319,081	430,132
Last Close Price	6550.00	6300.00	9979.80	8835.72	13670.11	18170.07
PE Ratio	73.75	31.39	10.36	12.57	22.61	19.03
PS Ratio	0.38	0.38	0.79	0.75	1.38	1.99
PB Ratio	0.46	0.43	0.70	0.68	1.12	1.58
P/TBV Ratio	0.63	0.60	0.88	0.74	1.23	1.73
P/FCF Ratio	-	-	61.45	23.75	28.69	30.17
P/OCF Ratio	-	-	9.75	8.77	11.22	10.39
EV/Sales Ratio	0.58	0.52	0.54	0.48	1.09	1.58
EV/EBITDA Ratio	9.16	7.29	6.02	3.82	9.22	12.73
EV/EBIT Ratio	29.95	17.97	10.50	5.42	14.18	18.64
EV/FCF Ratio	-4.49	-	42.36	15.01	22.65	23.92
Debt / Equity Ratio	0.26	0.24	0.12	0.02	0.03	0.05
Debt / EBITDA Ratio	3.47	2.93	1.45	0.16	0.33	0.46
Debt / FCF Ratio	-	-	10.18	0.62	0.82	0.87
Asset Turnover	0.80	0.79	0.71	0.75	0.67	0.67
Inventory Turnover	3.17	3.13	2.91	3.84	3.79	3.66
Quick Ratio	1.05	1.08	1.56	2.34	2.80	2.75
Current Ratio	1.76	1.79	2.26	3.06	3.37	3.36
Return on Equity (ROE)	-0.39%	0.53%	7.21%	5.83%	5.55%	8.92%
Return on Assets (ROA)	0.97%	1.42%	2.29%	4.11%	3.19%	3.56%
Return on Capital (ROIC)	1.21%	1.76%	2.79%	4.92%	3.84%	4.33%
Return on Capital Employed (ROCE)	1.90%	2.80%	4.10%	7.70%	5.90%	6.30%
Earnings Yield	1.44%	3.19%	9.65%	7.95%	4.42%	5.25%
FCF Yield	-33.57%	-23.30%	1.63%	4.21%	3.49%	3.31%
Dividend Yield	2.75%	2.86%	1.80%	2.04%	1.32%	0.99%
Payout Ratio	-	89.68%	18.16%	24.44%	27.81%	11.62%
Buyback Yield / Dilution	-6.15%	-0.12%	-0.02%	-0.16%	-0.05%	-0.05%
Total Shareholder Return	-3.40%	2.74%	1.78%	1.87%	1.27%	0.94%

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.